Search Results - "MIGLIORI, Giovanni B"
-
1
The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?
Published in The Lancet (British edition) (25-02-2012)“…[...] treatment-related outcome data have become available in programmes using second-line drugs such as capreomycin and paraaminosalicylic acid in settings of…”
Get full text
Journal Article -
2
Scaling up interventions to achieve global tuberculosis control: progress and new developments
Published in The Lancet (British edition) (19-05-2012)“…Summary Tuberculosis is still one of the most important causes of death worldwide. The 2010 Lancet tuberculosis series provided a comprehensive overview of…”
Get full text
Journal Article -
3
Effectiveness and safety of clofazimine in multidrug-resistant tuberculosis: a nationwide report from Brazil
Published in The European respiratory journal (01-03-2017)“…Although clofazimine is used to treat multidrug-resistant tuberculosis (MDR-TB), there is scant information on its effectiveness and safety. The aim of this…”
Get full text
Journal Article -
4
Coexistencia de tuberculosis y Covid-19
Published in Salud pública de México (25-03-2021)“…No disponible…”
Get full text
Journal Article -
5
Multidrug- and extensively drug-resistant tuberculosis, Germany
Published in Emerging infectious diseases (01-11-2008)“…We evaluated risk factors and treatment outcomes associated with multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) in Germany in…”
Get full text
Journal Article -
6
Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India
Published in PloS one (01-12-2011)“…India carries one quarter of the global burden of multi-drug resistant TB (MDR-TB) and has an estimated 2.5 million people living with HIV. Despite this…”
Get full text
Journal Article -
7
High rate of hypothyroidism in multidrug-resistant tuberculosis patients co-infected with HIV in Mumbai, India
Published in PloS one (23-10-2013)“…Adverse events (AEs) among HIV-infected patients with multidrug-resistant tuberculosis (MDR-TB) receiving anti-TB and antiretroviral treatments (ART) are…”
Get full text
Journal Article -
8
Harnessing the energy of the corporate sector to end TB: BE health
Published in Journal of clinical tuberculosis and other mycobacterial diseases (01-12-2020)“…The World Health Organization (WHO) estimates that 3 million people with TB are missing’ from the official information system. They remain often undiagnosed…”
Get full text
Journal Article -
9
Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence
Published in The European respiratory journal (01-11-2017)“…The treatment of multidrug-resistant (MDR) or extensively drug-resistant (XDR) tuberculosis (TB) remains a challenge for clinicians for several reasons,…”
Get full text
Journal Article -
10
Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis
Published in The Lancet (British edition) (08-08-2020)“…HIV-infection is associated with increased mortality during multidrug-resistant tuberculosis treatment, but the extent to which the use of antiretroviral…”
Get full text
Journal Article -
11
Multidrug-resistant tuberculosis – Authors' reply
Published in The Lancet (British edition) (27-07-2019)“…[...]this situation occurred only for a few analyses—primarily for the injectables and fluoroquinolones (see table 3 in our Article,1 although this was not the…”
Get full text
Journal Article -
12
Time to review treatment of isoniazid-resistant tuberculosis?
Published in The Lancet infectious diseases (01-02-2017)“…The 2014 reported global rate of isoniazid resistance not associated with rifampicin resistance was 9·5%,1 and the estimated prevalence of multidrug-resistant…”
Get full text
Journal Article -
13
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients
Published in PLoS medicine (01-08-2012)“…Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an individual patient data…”
Get full text
Journal Article -
14
Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes
Published in The European respiratory journal (01-07-2013)“…A meta-analysis for response to treatment was undertaken using individual data of multidrug-resistant tuberculosis (MDR-TB) (resistance to isoniazid and…”
Get full text
Journal Article -
15
Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso
Published in BMC infectious diseases (28-08-2009)“…Drug-resistant tuberculosis (DR-TB) is considered a real threat to the achievement of TB control. Testing of mycobacterial culture and testing of drug…”
Get full text
Journal Article -
16
History of tuberculosis and drug resistance
Published in The New England journal of medicine (03-01-2013)Get full text
Journal Article -
17
Drug-resistant tuberculosis
Published in Current opinion in pulmonary medicine (01-05-2013)“…PURPOSE OF REVIEWThis review discusses the recent evidence on epidemiology, diagnosis, and treatment of drug-resistant and multidrug-resistant (MDR)…”
Get full text
Journal Article -
18
Treatment Strategy for Rifampin-Susceptible Tuberculosis
Published in The New England journal of medicine (15-06-2023)“…To the Editor: With regard to the Two-Month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-Sensitive Tuberculosis (TRUNCATE-TB)…”
Get full text
Journal Article -
19
Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis
Published in The Lancet global health (01-11-2020)Get full text
Journal Article -
20
Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection
Published in Archivum Immunologiae et Therapiae Experimentalis (01-12-2009)“…Tuberculosis (TB) still represents a monumental problem, with more than two million deaths every year worldwide. The current diagnostics for TB offer…”
Get full text
Journal Article